Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 10, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tiago Fauth Reiterated (VRDN) at Buy and Held Target at $51 on, May 10th, 2023
Tiago Fauth of Credit Suisse, Reiterated "Viridian Therapeutics, Inc." (VRDN) at Buy and Held Target at $51 on, May 10th, 2023.
Tiago has made no other calls on VRDN in the last 4 months.
There are 3 other peers that have a rating on VRDN. Out of the 3 peers that are also analyzing VRDN, 0 agree with Tiago's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Tiago
- Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $47 on, Monday, April 10th, 2023
- Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $49 on, Thursday, March 30th, 2023
- Michael Higgins of "Ladenburg Thalmann" Reiterated at Strong Buy and Held Target at $40 on, Thursday, March 9th, 2023
